Vaccination

Japanese dengue vaccine becomes second approved by EU

Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.

Diseases, Conditions, Syndromes

EU regulator recommends clearing Takeda's dengue vaccine

The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.

Medical research

Targeting a human protein to squash SARS-CoV-2, other viruses

More than two years into the COVID-19 pandemic, people are realizing that the "new normal" will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers ...

Diseases, Conditions, Syndromes

Scientists rewrite the genesis of mosquito-borne viruses

Better designed vaccines for insect-spread viruses like dengue and Zika are likely after researchers discovered models of immature flavivirus particles were originally misinterpreted.

Diseases, Conditions, Syndromes

Jab-free dengue immunity could be just a click away

A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year.

page 1 from 6